Search Results for "valproate/valproic acid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for valproate/valproic acid. Results 51 to 54 of 54 total matches.

Lumateperone (Caplyta) for Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Jul 27, 2020  (Issue 1603)
such as valproic acid can increase lumateperone serum concentrations and is not recommended. Coadministration ...
The FDA has approved lumateperone (Caplyta — Intracellular Therapies), an oral second-generation antipsychotic, for once-daily treatment of schizophrenia in adults. It is the 13th second-generation antipsychotic drug to be approved by the FDA for this indication.
Med Lett Drugs Ther. 2020 Jul 27;62(1603):113-6 |  Show IntroductionHide Introduction

Aripiprazole (Abilify) for Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Feb 17, 2003  (Issue 1150)
), lithium (Eskalith, and others) or valproate (Depakote, and others). DOSAGE — Abilify is available in 10 ...
Aripiprazole (Abilify - Bristol-Myers Squibb/Otsuka), a quinolinone derivative, has been approved by the FDA for treatment of schizophrenia.
Med Lett Drugs Ther. 2003 Feb 17;45(1150):15-6 |  Show IntroductionHide Introduction

Coenzyme Q10

   
The Medical Letter on Drugs and Therapeutics • Feb 27, 2006  (Issue 1229)
. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine ...
Coenzyme Q10, a fat-soluble antioxidant also known as ubidecarenone, ubiquinone and CoQ10, is marketed as a dietary supplement in the US, both as a single ingredient and in various combination products.
Med Lett Drugs Ther. 2006 Feb 27;48(1229):19-20 |  Show IntroductionHide Introduction

Cannabis and Cannabinoids

   
The Medical Letter on Drugs and Therapeutics • Nov 18, 2019  (Issue 1585)
, and serum transaminase elevations. Patients also taking valproate and/ or clobazam were at increased risk ...
Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce intoxication or euphoria.
Med Lett Drugs Ther. 2019 Nov 18;61(1585):179-82 |  Show IntroductionHide Introduction